A study reporting on DiscGenics’ cell therapy phase 1 and 2 study has been selected as one of three of the best and most influential articles published in the International Journal of Spine Surgery in ...

Florey researchers have engineered a way to fool the immune system into accepting neural grafts as part of the body, rather ...

A tiny protein at the center of Parkinson’s disease also plays a surprising role in melanoma, a dangerous skin cancer. New research reveals that alpha-synuclein, which helps protect brain cells from ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients ...

DiscGenics, Inc., a privately held, late-stage clinical, biopharmaceutical company developing allogeneic, cell-based, regenerative therapies for musculoskeletal degeneration, today announced that the ...

The DNA of human cells consists of a sequence of about 3.1 billion building blocks. Cells go to great lengths to maintain the ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain inflammation.

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a ...

Immunizing mice with an edited Lyme disease-causing bacterial protein effectively protected them against the disease.

The randomized control period of the MINT trial has completed, and these newest data describe outcomes among patients who ...

Karl Koehler builds inner ear and skin organoids from human stem cells to model their development in health and disease.

The appointment of Dr. Banerjee culminates Artiva’s efforts to build a seasoned development team with strong expertise in autoimmunity and cell therapy that includes the following recent additions: ...